Relay Therapeutics, Inc. (RLAY)
Drugs • Health Care
Percentage
Change
| Mar 21 | Feb 22 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|
Net Income to Common | -338 | -276 | ||||
Net Income | -338 | -276 | ||||
Profit | -338 | -276 | ||||
Net Income Continuing | -338 | -276 | ||||
Pretax Income | -338 | -276 | ||||
Total Non-operating Income | 35 | 26 | ||||
Operating Income | -372 | -303 | ||||
Total Revenue | 10 | 15 | ||||
Total Costs and Expenses | -382 | -318 | ||||
Operating Expenses | -382 | -318 | ||||
Research and Development Expenses | -319 | -261 | ||||
Selling, General & Administrative Expenses | -77 | -57 | ||||
Other Operating Expenses | 13 | 0 |